Premenstrual syndrome: possibilities of care for symptom attenuation
DOI:
https://doi.org/10.11606/issn.1679-9836.v102i3e-196886Keywords:
Premenstrual Syndrome, Menstrual Cycle, Drug Therapy, Complementary TherapiesAbstract
Introduction: Premenstrual syndrome (PMS), with beggining in one or two weeks before menstruation, includes a recurring pattern of physical, affective and behavioral symptoms that can be exarcebated by external factors as life habits and socialeconomic conditions, affecting negatively the daily activities. Objective: Analyze the relationship between premenstrual syndrome and the possibility of rehabilitation. Method: Integrative literature review performed through reading of official portals of public agencies and the eletronic search in Biblioteca Virtual em Saúde (BVS), PubMed and Scientific Electronic Library Online (SciELO). Results: In this integrative review, it was selected 41 primary studies published within the last 5 years, available for free and in english and portuguese languages. Discussion: In regard of the non-pharmacological techniques, it was observed that physical exercise, diet, traditional iranian medicine, vitamine D supplementation and cognitive behavioral therapy had good efficiency in the attenuation of the PMS symptoms, as dysmenorrhea and mood changes; the treatment with auriculotherapy has shown similar results as the use of placebo; others as acupuncture and acupressure didn’t bring conclusive results. Between the pharmacological methods, the standard treatment is with combined oral contraceptives. Furthermore, the use of selective serotonin reuptake inhibitors (SSRIs) can increase the amount of serotonin for neurotransmission and consequently improve PMS symptoms. The selective estrogen receptor modulator offers a safe strategy to handle the symptoms, including menopauses. The use of selective progesterone receptor modulator, on the other hand, has shown better control of aggressive behaviors. At last, a multicentric study made in Sweden has shown promising results of endogenous neurosteroid when compared to the use of combined oral contraceptives. Conclusion: There are strong evidence of improvement of PMS symptoms in front of the many rehabilitation possibilities, whether they are pharmacological or non-pharmacological.
Downloads
References
Guyton, AC., Hall, JE. Tratado de fisiologia médica. 12º ed. Elsevier; 2019. p.1042-50
Da Silva JD, Farias DA, Raiol RDA, Estevam ECM, Coswig VS. Efeitos das fases do ciclo menstrual e da síndrome pré-menstrual sobre a aptidão física e percepção subjetiva de esforço em mulheres jovens. Pensar a Prática. 2018;21(3):645–57. doi: https://doi.org/10.5216/rpp.v21i3.49976
Henz A, Ferreira CF, Oderich CL, Gallon CW, de Castro JRS, Conzatti M, et al. Premenstrual syndrome diagnosis: A comparative study between the daily record of severity of problems (DRSP) and the premenstrual symptoms screening tool (PSST). Rev Bras Ginecol Obstet. 2018;40(1):20-5. doi:: https://doi.org/10.1055/s-0037-1608672
Yilmaz-Akyuz E, Aydin-Kartal,Y. The effect of diet and aerobic exercise on Premenstrual Syndrome: randomized controlled trial. Rev Nutricao. 2019; 32:1-10. doi: https://doi.org/10.1590/1678-9865201932e180246
Rezende APR, Alvarenga FR, Ramos M, Franken DL, Da Costa JSD, Pattussi MP et al. Prevalence of Premenstrual Syndrome and Associated Factors Among Academics of a University in Midwest Brazil. Rev Bras Ginecol Obstet. 2022;44(2):133-41. doi: https://doi.org/10.1055/s-0041-1741456
Masho SW, Adera T, South-Paul J. Obesity as a risk factor for premenstrual syndrome. J Psychosom Obstet Gynaecol. 2005;26(1):33-9. doi:: https://doi.org/10.1080/01443610400023049
Sadler C, Smith H, Hammond J, Bayly R, Borland S. Lifestyle factors, hormonal contraceptives and premenstrual symptoms: The UK Southampton Women’ s Survey. Eur PMC Funders Author anuscripts. 2011;19(3):391-6. doi: https://doi.org/10.1089/jwh.2008.1210
Longo SCM, Gigante DP, Laura M, Carret V, Fassa AG, Longo CM, et al. Estudo populacional de síndrome pré-menstrual Population study of premenstrual syndrome. Rev Saúde Pública. 2006;40(1):47-56. doi: https://doi.org/10.1590/S0034-89102006000100009
Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer? Einstein. 2010; 8(1):102-6.
Armour M, Ee CC, Hao J, Wilson TM, Yao SS, Smith CA. Acupuncture and acupressure for premenstrual syndrome. Cochrane Database Syst Rev. 2018;2018(8). doi: https://doi.org/10.1002/14651858.CD005290.pub2
Korelo RIG, Moreira NB, Miguel BA de C, Cruz C de G da, Souza NSP de, Macedo RMB de, et al. Effects of Auriculotherapy on treatment of women with premenstrual syndrome symptoms: A randomized, placebo-controlled clinical trial. Complement Ther Med. 2022;66(August 2020). doi: https://doi.org/10.1016/j.ctim.2022.102816
Schmidt K, Weber N, Steiner M, Meyer N, Dubberke A, Rutenberg D, et al. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial. Clin Nutr ESPEN. 2018;(24):22–30. doi: https://doi.org/10.1016/j.clnesp.2018.01.067
Prazeres LMA dos, Brito RG de, Ramos ES. Regular physical exercise, sedentarism and characteristics of dismenorrhea and premenstrual syndrome. Fisioter Mov. 2018;31(0):1-9. doi:: http://dx.doi.org/10.1590/1980-5918.031.AO18
Farahmand M, Khalili D, Ramezani Tehrani F, Amin G, Negarandeh R. Effectiveness of Echium amoenum on premenstrual syndrome: A randomized, double-blind, controlled trial. BMC Complement Med Ther. 2020;20(1):1-9. doi: https://doi.org/10.1186/s12906-020-03084-2
Heidari H, Amani R, Feizi A, Askari G, Kohan S, Tavasoli P. Vitamin D Supplementation for Premenstrual Syndrome-Related inflammation and antioxidant markers in students with vitamin D deficient: a randomized clinical trial. Sci Rep. 2019;9(1):1–8. doi: http://dx.doi.org/10.1038/s41598-019-51498-x
Alkhalaf Z, Kim K, Kuhr DL, Radoc JG, Purdue-Smithe A, Pollack AZ, et al. Markers of vitamin D metabolism and premenstrual symptoms in healthy women with regular cycles. Hum Reprod. 2021;36(7):1808-20. doi: http://dx.doi.org/10.1093/humrep/deab089
Arabnezhad L, Mohammadifard M, Rahmani L, Majidi Z, Ferns GA, Bahrami A. Effects of curcumin supplementation on vitamin D levels in women with premenstrual syndrome and dysmenorrhea: a randomized controlled study. BMC Complement Med Ther. 2022;22(1):1-11. doi: https://doi.org/10.1186/s12906-022-03515-2
Borji-Navan S, Mohammad-Alizadeh-Charandabi S, Esmaeilpour K, Mirghafourvand M, Ahmadian-Khooinarood A. Internet-based cognitive-behavioral therapy for premenstrual syndrome: a randomized controlled trial. BMC Womens Health. 2022;22(1):1-11. doi: https://doi.org/10.1186/s12905-021-01589-7
Ussher JM, Perz J. Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial. PLoS One. 2017;12(4):1-25. doi:: https://doi.org/10.1371/journal.pone.0175068
Santos DPC, Koehnlein EA. Frequência de Consumo de Alimentos Fonte de Fitoestrógenos e Intensidade dos Sintomas Climatéricos em Mulheres do Sudoeste do Paraná. Rev Saude Ci Online; 2022. Disponível em: https://rd.uffs.edu.br/handle/prefix/5449
Frigo M, de Barros E, Dos Santos PCB, Peres GL, Weber J, Zanelatto C, Koehnlein EA. Effects of a Cereal Bar with a Combination of Phytoestrogens on the Climacteric Symptoms: A Placebo-Controlled, Randomized Trial. Cochrane Database. Journal of the american nutrition association, 2022, 41(3), 325‐32. doi: https://doi.org/10.1080/07315724.2021.1884143
De OLIVEIRA, MT. A farinha de linhaça (Linun Usitatissimun L.) na prevenção e tratamento de doenças crônicas não transmissíveis: uma revisão de literatura. 2022. 37fl. (Trabalho de Conclusão de Curso – Monografia), Curso de Bacharelado em Nutrição, Centro de Educação e Saúde, Universidade Federal de Campina Grande, Cuité – Paraíba – Brasil, 2022. Disponível em: http://dspace.sti.ufcg.edu.br:8080/jspui/handle/riufcg/27239
de Wit AE, de Vries YA, de Boer MK, Scheper C, Fokkema A, Janssen CAH, et al. Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials. Am J Obstet Gynecol. 2021;225(6):624-33 doi: https://doi.org/10.1016/j.ajog.2021.06.090
Shehata NAA, Moety GAFA, El Wahed HAA, Fahim AS, Katta MA, Hussein GK. Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial. Reproductive Sci. 2020;27(2), 743-50. doi: https://doi.org/10.1007/s43032-019-00080-x
Takeda T, Shiina M, Chiba Y. Effectiveness of natural S-equol supplement for premenstrual symptoms: Protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open. 2018;8(7). doi: https://doi.org/10.1136/bmjopen-2018-023314
Kaltsouni E, Fisher PM, Dubol M, Hustad S, Lanzenberger R, Frokjaer VG, et al. Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator. Neuropsychopharmacology. 2021;46(8):1460-7. doi: http://dx.doi.org/10.1038/s41386-021-01010-9
Bixo M, Ekberg K, Poromaa IS, Hirschberg AL, Jonasson AF, Andréen L, et al. Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010) - A randomized controlled trial. Psychoneuroendocrinology. 2017; 80:46-55. doi: http://dx.doi.org/10.1016/j.psyneuen.2017.02.031
Comasco E, Kopp Kallner H, Bixo M, Hirschberg AL, Nyback S, de Grauw H, Epperson, C. N, & Sundström-Poromaa, I. (2021). Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial. Am J Psych, 178(3), 256-65. doi: https://doi.org/10.1176/appi.ajp.2020.20030286
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Maria Fernanda Oliveira da Silva, Luiza Orsatto de Azevedo, Maria Gabrielle de Oliveira Costa Campelo, Natália Conrado Wanderley, Mylena Kelly Motta Sobral, Geyslane Pereira Melo de Albuquerque
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
